Albumin-to-D-dimer ratios: A novel prognostic factor for evaluating first-line chemotherapy efficacy in advanced lung adenocarcinoma patients

2024-1-1

Artificial immortalization, number of therapy lines, and survival of patients with advanced gastric and esophagogastric adenocarcinoma

2024-1-1

High histone H3K18 lactylation level is correlated with poor prognosis in epithelial ovarian cancer

2024-1-1

Fluspirilene exerts an anti-glioblastoma effect through suppression of the FOXM1-KIF20A axis

2024-1-1

WTAP/CCND1 axis accelerates esophageal squamous cell carcinoma progression by MAPK signaling pathway

2024-1-1

Dongjun Jiang, Xiaoli Chen, Xiuting Li, Jian Qiu, Peng Xu, Xuezhi Li

2024-1-1

Innervation density and types of nerves in prostate cancer

2024-1-1

Treatment for SMARCB1 (INI-1) deficient sinonasal tumor: a single-institution study

2024-1-1

ARTN-GFRA3 axis induces epithelial-mesenchymal transition phenotypes, migration, and invasion of gastric cancer cells via KRAS signaling

2024-1-1

Circular RNA IARS modulates the progression and ferroptosis of osteosarcoma via sponging miR-188-5p from RAB14

2024-1-1

Calreticulin regulates the expression of MMP14 and ADAR1 through EIF2AK2 signaling to promote the proliferation and progression of malignant melanoma cells

2024-1-1

Impact of the number of therapy lines on survival in advanced gastric and esophagogastric adenocarcinoma - a real-world retrospective analysis from Croatia

2024-1-1

Characterization of the effects of thymol derivatives on colorectal cancer spheroids

2024-1-1

Allicin inhibits the growth of HONE-1 and HNE1 human nasopharyngeal carcinoma cells by inducing ferroptosis

2024-1-1

The role of polyethylenimine-functionalized gold nanoclusters carrying plasmid CMTM5 in impeding the malignant progression of prostate cancer cells by promoting EGFR endocytosis

2024-1-1

Three years follow-up of neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer

2024-1-1

microRNA-15a-5p suppresses hypoxia-induced tumor growth and chemoresistance in bladder cancer by binding to eIF5A2

2024-1-1

A response to: Artificial immortalization, number of therapy lines, and survival of patients with advanced gastric and esophagogastric adenocarcinoma

2024-1-1

Association between glutathione S-transferases M1 expression and treatment outcome in germ cell tumor patients

2024-1-1

The importance of sentinel lymph node intraoperative frozen analysis for indication of lateral neck dissection in patients with medullary thyroid cancer

2024-1-1

Trends in the treatment of human papillomavirus-associated oropharyngeal carcinoma in Slovakia

2024-1-1

FBXW7 inhibits the progression of ESCC by directly inhibiting the stemness of tumor cells

2024-1-1

Favorable prognostic significance of membranous β-catenin expression and negative prognostic significance of cytoplasmic β-catenin expression in pancreatic cancer

2024-1-1

The impact of neo/adjuvant treatment choices on prognosis for surgically treated small-cell neuroendocrine carcinoma of the cervix

2024-1-1

Tumor-derived autophagosome vaccines combined with immune adjuvants mediate antitumor immune responses via the neoantigen pathway

2024-1-1

Sintilimab, bevacizumab biosimilar, and HAIC for unresectable hepatocellular carcinoma conversion therapy: a prospective, single-arm phase II trial

2024-1-1

Copy number variations in malignant melanoma: genomic regions, biomarkers, and therapeutic targets

2024-1-1

Silencing of lncRNA LOC105376794 promotes migration, invasion, and gefitinib resistance of lung adenocarcinoma cells with EGFR 19del mutation by ATF4/CHOP axis and ERK phosphorylation

2024-1-1

Impact of multiple primary cancers on overall survival of patients with hepatocellular carcinoma

2024-1-1

Nanocomposite hydrogels in skin cancer medicine

2024-1-1

Mouse models for cancer research – current state and the perspective

2024-1-1

Unlocking the paracrine crosstalk: adipocyte-derived factors affect carbonic anhydrase IX expression in colon and breast cancer cells

2024-1-1

The role of RRS1 in breast cancer cells metastasis and AEG-1/AKT/c-Myc signaling pathway

2024-1-1

Vitamin D supplementation in cancer prevention and the management of cancer therapy

2024-1-1

HER2 status results in an unstable switch from primary to recurrent breast cancer

2024-1-1

Efficacy and safety analysis of anlotinib in combination with immune checkpoint inhibitors for second-line and subsequent extensive-stage small-cell lung cancer

2024-1-1

USP36 plays an oncogenic role in colorectal cancer cells

2024-1-1

Tiam1 regulates proliferation, invasion, and differentiation in neuroblastoma through the Tiam1/Rac1 signaling pathway

2024-1-1

NEK2 promotes TP53 ubiquitination to enhance the proliferation and migration of TP53 wild-type glioblastoma cells

2024-1-1

miR-124 delivered by BM-MSCs-derived exosomes targets MCT1 of tumor-infiltrating Treg cells and improves ovarian cancer immunotherapy

2024-1-1

CCDC86 promotes the aggressive behavior of nasopharyngeal carcinoma by positively regulating EGFR and activating the PI3K/Akt signaling

2024-1-1

CHAC1 promotes cell ferroptosis and enhances radiation sensitivity in thyroid carcinoma

2024-1-1

The role of HMGA2 in activating the IGFBP2 expression to promote angiogenesis and LUAD metastasis via the PI3K/AKT/VEGFA signaling pathway

2024-1-1

The gene RAD51AP1 promotes the progression of pancreatic cancer via the PI3K/Akt/NF-κB signaling pathway

2024-1-1

Can hypoxia marker carbonic anhydrase IX serve as a potential new diagnostic marker and therapeutic target of non-small cell lung cancer?

2024-1-1

Downregulation of WNK4 expression facilitates the proliferation of gastric cancer cells via activation of the STAT3 signaling pathway

2024-1-1

Oncogenic DDX46 promotes pancreatic cancer development and gemcitabine resistance by facilitating the JMJD6/CDK4 signaling pathway

2024-1-1

Participation of suicide gene extracellular vesicles in metastasis prevention

2024-1-1

miR-124 delivered by BM-MSCs-derived exosomes targets MCT1 of tumor-infiltrating Treg cells and improves ovarian cancer immunotherapy

2023-11-14

Expression of Tmem41b and MMP13 associated with poor outcome in osteosarcomas

2023-8-20